Form 4: ICAD Inc. Director Michael Doyle Acquires 30,000 Stock Options

ICAD Inc. director Michael Doyle was granted 30,000 stock options on January 3, 2025, which vest quarterly over a twelve-month period.

Summary

• Michael Doyle, a director at ICAD Inc., was granted 30,000 stock options on January 3, 2025.
• The options have an exercise price of $2.06 per share.
• The options vest quarterly over a twelve-month period starting from the grant date.
• The options expire on January 3, 2035.
• The underlying security for the options is ICAD Inc. common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There are no negative implications or unusual circumstances.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages the director's continued service and contribution to the company.

Industry Context

The granting of stock options to directors is a common practice in corporate governance to incentivize performance and align interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for directors and executives across various industries.
• The vesting schedule of quarterly over twelve months is a typical approach to ensure continued service and performance.
• The exercise price of $2.06 is specific to ICAD Inc. and would need to be compared to similar companies to assess its competitiveness.

Stakeholder Impact

• The stock option grant may have a positive impact on shareholders by aligning the director's interests with the company's performance.

Key Dates

Keywords

stock options, director, ICAD Inc., equity, vesting, executive compensation